Intravenous Stem Cell Therapy - Regenerative Medicine Overview

Intravenous Stem Cell Therapy - Regenerative Medicine Overview

IV Stem Cell Therapy is an advanced regenerative treatment that delivers mesenchymal stem cells (MSCs) or other stem cell types via intravenous infusion to promote systemic healing and anti-aging effects. These cells possess the unique ability to self-renew and differentiate into various tissue types while modulating inflammation and immune responses.

Key Benefits

✔ Systemic Regeneration: Cells migrate to damaged areas (brain, joints, organs)

✔ Paracrine Signaling: Releases growth factors (VEGF, FGF, HGF) for tissue repair

✔ Immunomodulation: Reduces chronic inflammation (e.g., autoimmune conditions)

✔ Anti-Aging Potential: May extend healthspan via telomere support

Cell Sources & Types

▸ Autologous: Patient's own adipose/fat or bone marrow-derived MSCs

▸ Allogeneic: Donor-derived umbilical cord/placental MSCs (off-the-shelf)

▸ Induced Pluripotent (iPSCs): Reprogrammed adult cells (investigational)

Clinical Applications

▶ Neurological: Alzheimer’s, Parkinson’s, stroke recovery (Phase II trials)

▶ Orthopedic: Osteoarthritis, cartilage repair (FDA-approved for knee OA)

▶ Autoimmune: MS, Crohn’s, RA (modulates Th1/Th17 responses)

▶ Aesthetic: Skin rejuvenation, hair regrowth

Treatment Protocol

1. Cell Harvesting: Liposuction (adipose) or bone marrow aspiration (~2hr procedure)

2. Processing: Lab isolation/expansion (3-4 weeks for autologous)

3. IV Infusion: 50-200 million cells administered (~60 mins)

4. Adjuvant Therapies: Often paired with PRP or exosomes

Safety & Efficacy

• FDA Status: Limited approvals (e.g., cord blood for blood cancers); most uses investigational

• Adverse Events: Rare (<1% risk of fever/allergic reaction)

• Peak Effects: 3-6 months post-treatment